Navigation Links
Glytec Adds Pediatric Insulin Dosing to its IV and SubQ FDA Clearances
Date:5/22/2012

GREENVILLE, S.C., May 22, 2012 /PRNewswire/ -- Glytec, LLC, headquartered in Greenville, SC, announced today that its Glucommander™ 2.0 Enterprise software has been cleared by the FDA for pediatric use, ages 2 - 17. Glytec's Glucommander was the first insulin dosing software to be cleared for adult (ages 18+) intravenous use; it is the only company to achieve specific clearance for subcutaneous use, and now it is the only company cleared to offer this technology to hospitals caring for children.

Hypoglycemia, hyperglycemia, and, in particular, increased glucose variability are prevalent with pediatric intensive care patients and those children suffering with diabetes in general, all of which are issues associated with increased length of stay and mortality rates. Children pose unique treatment challenges related to medications, dietary control, meal planning and physical activity, all of which necessitate effective glycemic control.

Commenting on the announcement, Trefor Thomas, CEO & President of Glytec, said, "We're very pleased that the FDA has cleared our system for use with all children as young as two, and we expect to see substantial improvement in their outcomes, similar to what adult patients have been experiencing with our system for years."

Glytec's clinician-developed, algorithm-based insulin-dosing software is a network based application designed to consider each patient's insulin sensitivity to safely stabilize excursions while achieving and maintaining glucose levels within a clinician defined target range, allowing patients to achieve safe normoglycemia. This can translate to reductions in length of stay, infection rates, readmission rates, comorbidity, and even mortality.

Thomas added, "This latest advance again demonstrates Glytec to be the industry leader in glycemic management. Our organization has worked hard to earn the FDA clearance for an application designed around the unique needs of children, and we are excited to be the first to get clearance for pediatric dosing. We will continue to work on other ways to extend the safety and efficacy of insulin as a way to control elevated blood glucose levels without causing hypoglycemia."

About Glytec, LLC
Founded in 2006 and headquartered in Greenville, South Carolina, Glytec (http://www.GlytecSystems.com) is leading the way with next generation glycemic control management systems. Glytec offers the only glycemic management system cleared for both adults and children. For further information, contact: William J. Nicholson, Marketing Director, Glytec, LLC – (864) 263 4178 – bnicholson@glytecsystems.com

Visit Glytec at NTI/AACN in Orlando, May 22 to 24 – Booth #2437


'/>"/>
SOURCE Glytec, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Particle Sciences and Pernix Therapeutics Enter into an Agreement to Develop a Pediatric Dermatology Product
3. Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma
4. Computer-Assisted Tools Alert Pediatricians to Obese Patients
5. Middleton Pediatrics Now Using Spot to Screen Patients
6. Texas Childrens Hospital, Lead Study Center, Announces U.S. Food and Drug Administration Approval of EXCOR® Pediatric Ventricular Assist Device for Use in United States
7. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
8. NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD
9. Pediatricians and Psychiatrists Debate Wider Diagnosing, Prescribing Guidelines for ADHD
10. Spot Helps Redefine the Pediatric Office of the Future
11. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity ... Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and ... policies that can help reduce tobacco use. The initiative brings together two organizations ...
(Date:4/28/2016)... Illinois (PRWEB) , ... April ... ... the leading provider of enterprise Data Center Infrastructure Management solutions, announces today ... focuses on feature enhancements in the area of capacity management and optimization, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and ... Surgery Collaborative Residency Network. The platform is scheduled to launch in July 2016 ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission ... Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction ... an accreditation distinction. ACHC provides a wide range of pharmacy accreditation services that ...
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
Breaking Medicine News(10 mins):